Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma.
Saved in:
| Title: | Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma. |
|---|---|
| Authors: | Hagerty BL; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Fekrmandi F; Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Schneider T; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Fountzilas C; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Stiles Z; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Kukar M; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Calvo B; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Cherkassky L; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA. |
| Source: | Journal of surgical oncology [J Surg Oncol] 2024 Oct; Vol. 130 (5), pp. 1014-1022. Date of Electronic Publication: 2024 Aug 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-9098 |
|---|---|
| DOI: | 10.1002/jso.27803 |
